These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29957392)

  • 1. Different features between pediatric-onset and adult-onset patients who are seropositive for MOG-IgG: A multicenter study in South China.
    Chen L; Chen C; Zhong X; Sun X; Zhu H; Li X; Yang H; Shu Y; Chang Y; Hu X; Lu Z; Peng L; Qiu W
    J Neuroimmunol; 2018 Aug; 321():83-91. PubMed ID: 29957392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and outcomes of myelin oligodendrocyte glycoprotein antibody-seropositive optic neuritis in varying age groups: A cohort study in China.
    Song H; Zhou H; Yang M; Xu Q; Sun M; Wei S
    J Neurol Sci; 2019 May; 400():83-89. PubMed ID: 30904690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes.
    Waters P; Fadda G; Woodhall M; O'Mahony J; Brown RA; Castro DA; Longoni G; Irani SR; Sun B; Yeh EA; Marrie RA; Arnold DL; Banwell B; Bar-Or A;
    JAMA Neurol; 2020 Jan; 77(1):82-93. PubMed ID: 31545352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients.
    Zhao Y; Tan S; Chan TCY; Xu Q; Zhao J; Teng D; Fu H; Wei S
    Br J Ophthalmol; 2018 Oct; 102(10):1372-1377. PubMed ID: 29363529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic features of initial demyelinating events associated with serum MOG-IgG.
    Orlandi R; Mariotto S; Ferrari S; Gobbin F; Sechi E; Capra R; Mancinelli CR; Bombardi R; Zuliani L; Zoccarato M; Rossi F; Camera V; Ferraro D; Benedetti MD; Reindl M; Gajofatto A
    J Neuroimmunol; 2020 Jul; 344():577260. PubMed ID: 32442864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and prognosis of myelin oligodendrocyte glycoprotein antibody-seropositive paediatric optic neuritis in China.
    Song H; Zhou H; Yang M; Tan S; Wang J; Xu Q; Liu H; Wei S
    Br J Ophthalmol; 2019 Jun; 103(6):831-836. PubMed ID: 30049802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of children with myelin oligodendrocyte glycoprotein antibody-related disorders.
    Konuskan B; Yildirim M; Gocmen R; Okur TD; Polat I; Kilic H; Saltik S; Ozturk Z; Gucuyener K; Altunbasak S; Celik T; Kose G; Yilmaz A; Komur M; Kayilioglu H; Anlar B
    Mult Scler Relat Disord; 2018 Nov; 26():1-7. PubMed ID: 30212767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.
    Lee HJ; Kim B; Waters P; Woodhall M; Irani S; Ahn S; Kim SJ; Kim SM
    J Neuroinflammation; 2018 Oct; 15(1):302. PubMed ID: 30382857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.
    Chen JJ; Flanagan EP; Jitprapaikulsan J; López-Chiriboga ASS; Fryer JP; Leavitt JA; Weinshenker BG; McKeon A; Tillema JM; Lennon VA; Tobin WO; Keegan BM; Lucchinetti CF; Kantarci OH; McClelland CM; Lee MS; Bennett JL; Pelak VS; Chen Y; VanStavern G; Adesina OO; Eggenberger ER; Acierno MD; Wingerchuk DM; Brazis PW; Sagen J; Pittock SJ
    Am J Ophthalmol; 2018 Nov; 195():8-15. PubMed ID: 30055153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
    Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
    J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High titers of myelin oligodendrocyte glycoprotein antibody are only observed close to clinical events in pediatrics.
    Lui A; Chong J; Flanagan E; Abrams AW; Krysko KM; Arikan B; Francisco C; Rutatangwa A; Waubant E; Ziaei A
    Mult Scler Relat Disord; 2021 Nov; 56():103253. PubMed ID: 34517190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and relevance of IgM, and IgA antibodies against MOG in MOG-IgG-associated disease.
    Pedreño M; Sepúlveda M; Armangué T; Sabater L; Martínez-Hernandez E; Arrambide G; Blanco Y; Llufriu S; Martínez-Lapiscina EH; Mulero P; Sola-Valls N; Ruiz-García R; Tintoré M; Dalmau J; Graus F; Saiz A
    Mult Scler Relat Disord; 2019 Feb; 28():230-234. PubMed ID: 30623863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelin oligodendrocyte glycoprotein antibody-associated demyelination: comparison between onset phenotypes.
    Zhou Y; Jia X; Yang H; Chen C; Sun X; Peng L; Kermode AG; Qiu W
    Eur J Neurol; 2019 Jan; 26(1):175-183. PubMed ID: 30153357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and MRI phenotype of children with MOG antibodies.
    Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T
    Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
    J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical spectrum, treatment and outcome of myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease in children: a tertiary care experience.
    Serin HM; Yilmaz S; Simsek E; Kanmaz S; Eraslan C; Aktan G; Tekgul H; Gokben S
    Acta Neurol Belg; 2021 Feb; 121(1):231-239. PubMed ID: 33231843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
    Jarius S; Kleiter I; Ruprecht K; Asgari N; Pitarokoili K; Borisow N; Hümmert MW; Trebst C; Pache F; Winkelmann A; Beume LA; Ringelstein M; Stich O; Aktas O; Korporal-Kuhnke M; Schwarz A; Lukas C; Haas J; Fechner K; Buttmann M; Bellmann-Strobl J; Zimmermann H; Brandt AU; Franciotta D; Schanda K; Paul F; Reindl M; Wildemann B;
    J Neuroinflammation; 2016 Nov; 13(1):281. PubMed ID: 27802825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.
    Jitprapaikulsan J; Chen JJ; Flanagan EP; Tobin WO; Fryer JP; Weinshenker BG; McKeon A; Lennon VA; Leavitt JA; Tillema JM; Lucchinetti C; Keegan BM; Kantarci O; Khanna C; Jenkins SM; Spears GM; Sagan J; Pittock SJ
    Ophthalmology; 2018 Oct; 125(10):1628-1637. PubMed ID: 29716788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing.
    Sechi E; Buciuc M; Pittock SJ; Chen JJ; Fryer JP; Jenkins SM; Budhram A; Weinshenker BG; Lopez-Chiriboga AS; Tillema JM; McKeon A; Mills JR; Tobin WO; Flanagan EP
    JAMA Neurol; 2021 Jun; 78(6):741-746. PubMed ID: 33900394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders.
    López-Chiriboga AS; Majed M; Fryer J; Dubey D; McKeon A; Flanagan EP; Jitprapaikulsan J; Kothapalli N; Tillema JM; Chen J; Weinshenker B; Wingerchuk D; Sagen J; Gadoth A; Lennon VA; Keegan BM; Lucchinetti C; Pittock SJ
    JAMA Neurol; 2018 Nov; 75(11):1355-1363. PubMed ID: 30014148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.